Research Progress of Immunotherapy and Molecular Targeted Therapy for Anaplastic Thyroid Carcinoma
Anaplastic Thyroid Carcinoma(ATC)is a pathological type of thyroid cancer,which has the characteristics of high malignancy and poor therapeutic effect.So far,there is no specific treatment.Immunotherapy can effectively activate the body's immune system to eliminate tumors,achieve lasting response and prolong survival time,while molecular targeted therapy can selectively kill tumor cells against specific targets with less side effects.Both of them have become new ideas for clinical treatment of ATC and have received great attention.This paper reviews the research progress of immunotherapy and molecular targeted therapy for ATC,aiming to provide reference for the clinical treatment of this disease.
NETL
NSTL
万方数据
